A new study produces the first disease-specific, psychometrically robust and validated measure of quality life for patients with locally recurrent rectal cancer.
Sure, ad-blocking software does a great job at blocking ads, but it also blocks useful features of our website. For the best site experience please disable your AdBlocker.
